Figures & data
Table 1. Primer sequences
Figure 1. Immunocytochemical staining. A: Negatively stained hBMMSCs for blank control; B: negatively stained hBMMSCs for negative control; C: negatively stained hBMMSCs for CD34; D: positively stained hBMMSCs for CD44.
![Figure 1. Immunocytochemical staining. A: Negatively stained hBMMSCs for blank control; B: negatively stained hBMMSCs for negative control; C: negatively stained hBMMSCs for CD34; D: positively stained hBMMSCs for CD44.](/cms/asset/c9b25944-5e9f-480e-a5b9-ec8433615de0/kbie_a_2012618_f0001_oc.jpg)
Figure 2. miRNA microarray results of hBMMSCs (A1/A2/A3) and those cultured by osteogenic induction for 21 days (B1/B2/B3).
![Figure 2. miRNA microarray results of hBMMSCs (A1/A2/A3) and those cultured by osteogenic induction for 21 days (B1/B2/B3).](/cms/asset/e9c8c422-6352-41f9-a5b5-ef5b4e202753/kbie_a_2012618_f0002_oc.jpg)
Figure 4. Expression of miR-28 significantly increased during the osteogenic differentiation of hBMMSCs. A: RUNX2 mRNA expression on days 1, 10 and 15 detected by qRT-PCR; B: AKP activity detected by AKP assay kits; C: miR-28 expression on days 1, 5, 10 and 15 detected by qRT-PCR (n = 3).
![Figure 4. Expression of miR-28 significantly increased during the osteogenic differentiation of hBMMSCs. A: RUNX2 mRNA expression on days 1, 10 and 15 detected by qRT-PCR; B: AKP activity detected by AKP assay kits; C: miR-28 expression on days 1, 5, 10 and 15 detected by qRT-PCR (n = 3).](/cms/asset/263e13b6-177b-46ba-bef5-284dcae18741/kbie_a_2012618_f0004_b.gif)